Worth noting:

Recordati announces FDA approval of ISTURISA®  new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here

Corcept Therapeutics announces FDA Relacolirant new drug application to treat Hypercortisolism   .  Read more

From Crinetics Pharmaceuticals – FDA accepts Crinetics new drug Paltusotine’s application for adults with acromegaly . Read more

Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more 

New support site from Chiesi; Rethink acromegaly

Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.

Chiesi relaunches a patient-facing website for Mycapssa.

Latest Videos

Inside Camurus: Dr. Markus Johnsson talks about FluidCrystal® technology and next-generation treatment innovations

In the latest episode of the Pituitary World News podcast, Jorge D. Faccinetti sits down with Dr. Markus Johnsson, Senior VP of R&D at Camurus, to explore the fascinating world of FluidCrystal® technology. This innovative approach promises to revolutionize the way we think about drug delivery, providing long-lasting solutions for chronic diseases particularly for people with acromegaly.

Endo 2025 interviews; conversations with advocates, nurses, and specialty pharmacy executives

This week we bring you my chats from ENDO 2025 with  Jill Sisco, president of the Acromegaly Community, Dr. Chris Yedinak, retired professor at Oregon Health and Science University, adjunct professor at Mount Marty University, and Alan Erck, Chief Commercial Officer at Anovo Pharmacy.  Learn their outlook for patient care and support.

From Endo 2025, Amplifying Expert Voices: my conversation with our friends from Recordati Rare Diseases

We caught up with a group of top executives at Recordati at ENDO 2025 and asked them about their plans, challenges and opportunities and, importantly, their outlook for new therapies in acromegaly and Cushing’s.

Perspectives from inside Endo 2025 – My chats with Crinetics Pharmaceuticals’ Jacqui Kirby, Stephanie Kallay, and Dr. Peter Trainer

Through our conversations with leading pituitary experts, physicians, nurses, industry executives, researchers, patient advocates, and other key stakeholders, we gain unique insights from the fascinating world of pituitary disease research and treatment.

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D. Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

Live Talk on Demand

Listen in your favorite platform